Terms: = Head and neck cancer AND PDCD1LG2, Q9BQ51, 80380, ENSG00000197646, MGC142240, Btdc, PDCD1L2, CD273, B7DC, MGC142238, PD-L2, PDL2, bA574F11_2
98258 results:
1. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
Li S; Liu Z; Chen Q; Chen Y; Ji S
Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
[TBL] [Abstract] [Full Text] [Related]
2. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer.
Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC
Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274
[TBL] [Abstract] [Full Text] [Related]
3. Thyroid Malignancy in Patients Who Underwent Thyroidectomy for Multinodular Goiter and Solitary Thyroid Nodule.
Gedamu D; Shimels T; Kassie D; Chanyalew Z; Eyasu M
JCO Glob Oncol; 2024 May; 10():e2300322. PubMed ID: 38815179
[TBL] [Abstract] [Full Text] [Related]
4. Surgical and multimodal treatment of metastatic oesophageal cancer: retrospective cohort study.
Knipper K; Lemties J; Krey T; Lyu SI; Wirsik NM; Schiffmann LM; Fuchs HF; Gebauer F; Schröder W; Popp FC; Quaas A; Schlößer HA; Bruns CJ; Schmidt T
BJS Open; 2024 May; 8(3):. PubMed ID: 38814750
[TBL] [Abstract] [Full Text] [Related]
5. Radioactive iodine refractoriness in Middle Eastern differentiated thyroid cancer: clinical outcome and risk factor analysis.
Parvathareddy SK; Siraj AK; Siraj N; Ahmed SO; Al-Rasheed M; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2024; 15():1326976. PubMed ID: 38812819
[TBL] [Abstract] [Full Text] [Related]
6. [Study on mechanism of inhibiting proliferation of head and neck cancer cells by citral, active ingredient of lemon essential oil].
Chen L; Zhang YJ; Qin HW; Hu WJ; Liu YJ; Xiao GS; DU HH; Yang DL
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2364-2375. PubMed ID: 38812137
[TBL] [Abstract] [Full Text] [Related]
7. Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
Fang Q; Yuan J; Zhang X; Dai L; Luo R
BMC Cancer; 2024 May; 24(1):656. PubMed ID: 38811899
[TBL] [Abstract] [Full Text] [Related]
8. Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
Yang X; Zheng X; Hu S; Huang J; Zhang M; Huang P; Wang J
BMC Cancer; 2024 May; 24(1):654. PubMed ID: 38811891
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
[TBL] [Abstract] [Full Text] [Related]
10. The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma.
Cheng A; Xu Q; Li B; Zhang L; Wang H; Liu C; Han Z; Feng Z
Cell Death Dis; 2024 May; 15(5):376. PubMed ID: 38811531
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of the Dosimetric Index from IMRT and Rapid arc Plan for Oropharyngeal cancer with Simultaneous Integrated Boost (SIB) Technique in Combination with EUD-based NTCP and TCP Radiobiological Models.
Dashnamoorthy S; Jeyasingh E; Rajamanickam K; Ahmed I
Asian Pac J Cancer Prev; 2024 May; 25(5):1515-1528. PubMed ID: 38809623
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Ability of Expression of Myofibroblasts in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shete MV; Shete AV; Buva K; Channe PP; Sapkal R; Nerkar Rajbhoj A
Asian Pac J Cancer Prev; 2024 May; 25(5):1477-1486. PubMed ID: 38809619
[TBL] [Abstract] [Full Text] [Related]
13. Radiotherapy for parotid cancer: 10 years of experience in a single center.
Lachgar A; N'Da G; Nouni K; El Kacemi H; Kebdani T; Hassouni K
Otolaryngol Pol; 2024 Jun; 78(3):1-6. PubMed ID: 38808641
[TBL] [Abstract] [Full Text] [Related]
14. Deep Learning-Based Prediction of Radiation Therapy Dose Distributions in Nasopharyngeal Carcinomas: A Preliminary Study Incorporating Multiple Features Including Images, Structures, and Dosimetry.
Wang Y; Piao Z; Gu H; Chen M; Zhang D; Zhu J
Technol Cancer Res Treat; 2024; 23():15330338241256594. PubMed ID: 38808514
[No Abstract] [Full Text] [Related]
15. Influence of maximum diameter on fine-needle aspiration biopsy outcomes in ACR TI-RADS 5 thyroid nodules.
Cao SL; Shi WY; Niu YR; Zhao ZL; Wei Y; Wu J; Peng LL; Li Y; Yu MA
Front Endocrinol (Lausanne); 2024; 15():1374888. PubMed ID: 38808118
[TBL] [Abstract] [Full Text] [Related]
16. Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma.
Chen P; Fu C; Shen L; Fei Z; Luo M; Chen Y; Li H
BMC Health Serv Res; 2024 May; 24(1):676. PubMed ID: 38807104
[TBL] [Abstract] [Full Text] [Related]
17. FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis.
Guo S; Huang B; You Z; Luo Z; Xu D; Zhang J; Lin J
BMC Oral Health; 2024 May; 24(1):625. PubMed ID: 38807101
[TBL] [Abstract] [Full Text] [Related]
18. Practical surgical technique using the SMISS approach for lip reduction in involuted lip infantile hemangiomas.
Chen Q; Chang SJ; Gao W; Chang L; Qiu Y; Lin X
BMC Pediatr; 2024 May; 24(1):368. PubMed ID: 38807073
[TBL] [Abstract] [Full Text] [Related]
19. Cellular mechanisms mediating the anti-cancer effects of carnosol on gingiva carcinoma.
Gassib N; Issa H; Loubaki L; Behaz S; Almutairi MH; Rouabhia M; Semlali A
Sci Rep; 2024 May; 14(1):12266. PubMed ID: 38806527
[TBL] [Abstract] [Full Text] [Related]
20. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
[TBL] [Abstract] [Full Text] [Related]
[Next]
